| 초록 |
The objectives of my talk are as follows: 1. Review the role of complement system in health and disease 2. Explain the rationale and mechanisms that drive complement dysregulation across glomerular diseases 3. Describe the implications of complement dysregulation in individual glomerular diseases including C3G, IgA Nephropathy and membranous nephropathy 4. Highlight recent outcomes from clinical trials evaluating the role of anti-complement therapies for specific glomerular diseases and discuss future directions |